SAFETY OF COMBINED PIRFENIDONE AND NINTEDANIB IN PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS

被引：2
|
作者：
Flaherty, K. R. [1 ]
Fell, C. D. [2 ]
Huggins, J. T. [3 ]
Nunes, H. [4 ]
Sussman, R. [5 ]
Valenzuela, C. [6 ]
Petzinger, U. [7 ]
Stauffer, J. L. [8 ]
Gilberg, F. [9 ]
Bengus, M. [9 ]
Wijsenbeek, M. [10 ]
机构：
[1] Univ Michigan, Ann Arbor, MI USA
[2] Univ Calgary, Calgary, AB, Canada
[3] Med Univ South Carolina, Charleston, SC USA
[4] Hop Avicenne, Paris, France
[5] Atlantic Hlth Syst, Overlook Med Ctr, Summit, NJ USA
[6] Hosp Univ La Princesa, Inst Invest Princesa, Madrid, Spain
[7] Clinipace Accovion GmbH, Eschborn, Germany
[8] Genentech Inc, San Francisco, CA 94080 USA
[9] F Hoffman La Roche Ltd, Basel, Switzerland
[10] Erasmus Univ, Med Ctr, Rotterdam, Netherlands
来源：
THORAX | 2017年 / 72卷
关键词：
D O I：
10.1136/thoraxjnl-2017-210983.453
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
M31
引用
收藏
页码：A253 / A254
页数：2
相关论文
共 50 条
  • [21] Combination Nintedanib and Pirfenidone for Treatment of Idiopathic Pulmonary Fibrosis Reply
    Vancheri, Carlo
    Kreuter, Michael
    Richeldi, Luca
    Quaresma, Manuel
    Stowasser, Susanne
    Wuyts, Wim A.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 198 (08) : 1105 - 1106
  • [22] A comparison of pirfenidone versus nintedanib for the management of idiopathic pulmonary fibrosis
    Naqvi, Marium
    D'Ancona, Grainne
    West, Alex
    EUROPEAN RESPIRATORY JOURNAL, 2018, 52
  • [23] Nintedanib and Pirfenidone as a Bridge to Lung Transplant in Idiopathic Pulmonary Fibrosis
    Li, D.
    Mason, W.
    Hoy, H.
    Robbins, I.
    Loyd, J.
    Lancaster, L.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
  • [24] TRENDS IN NINTEDANIB AND PIRFENIDONE UTILIZATION FOR IDIOPATHIC PULMONARY FIBROSIS IN AUSTRALIA
    Cox, I
    De Graaff, B.
    Corte, T.
    Glaspole, I
    Chambers, D.
    Moodley, Y.
    Teoh, A.
    Walters, E.
    Palmer, A.
    RESPIROLOGY, 2021, 26 : 92 - 92
  • [25] Safety Of The Combined Use Of Pirfenidone And Nintedanib In Patients With Idiopathic Pulmonary Fibrosis (ipf): Results From An Interim Analysis After 12 Weeks
    Flaherty, K. R.
    Sussman, R.
    Pesci, A.
    Nunes, H.
    Acosta, O.
    Petzinger, U.
    Stauffer, J.
    Gilberg, F.
    Bengus, M.
    Lancaster, L. H.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 195
  • [26] Safety and efficacy of pirfenidone and nintedanib in patients with idiopathic pulmonary fibrosis and carrying a telomere-related gene mutation
    Justet, Aurelien
    Klay, Dymph
    Porcher, Raphael
    Cottin, Vincent
    Ahmad, Kais
    Molina, Maria Molina
    Nunes, Hilario
    Reynaud-Gaubert, Martine
    Naccache, Jean Marc
    Manali, Effrosyni
    Froidure, Antoine
    Jouneau, Stephane
    Wemeau, Lidwine
    Andrejak, Claire
    Gondouin, Anne
    Hirschi, Sandrine
    Blanchard, Elodie
    Bondue, Benjamin
    Bonniaud, Philippe
    Tromeur, Cecile
    Prevot, Gregoire
    Marchand-Adam, Sylvain
    Funke-Chambour, Manuela
    Gamez, Anne Sophie
    Ba, Ibrahima
    Papiris, Spyridon
    Grutters, Jan
    Crestani, Bruno
    van Moorsel, Coline
    Kannengiesser, Caroline
    Borie, Raphael
    EUROPEAN RESPIRATORY JOURNAL, 2021, 57 (02)
  • [27] Utilization of Pirfenidone and Nintedanib in Patients with Idiopathic Pulmonary Fibrosis: An Analysis of US Claims Data
    Viscidi, Emma
    Wang, Nasha
    Hall, Susan
    Gallagher, Diana
    Eaton, Susan
    Dilley, Anne
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2017, 26 : 577 - 578
  • [28] Safety of nintedanib added to pirfenidone treatment for idiopathic pulmonary fibrosis (vol 52, 1800230, 2018)
    Flaherty, Kevin R.
    Fell, Charlene D.
    Huggins, J. Terrill
    Nunes, Hilario
    Sussman, Robert
    Valenzuela, Claudia
    Petzinger, Ute
    Stauffer, John L.
    Gilberg, Frank
    Bengus, Monica
    Wijsenbeek, Marlies
    EUROPEAN RESPIRATORY JOURNAL, 2018, 52 (04)
  • [29] Tolerability and safety of nintedanib in elderly patients with idiopathic pulmonary fibrosis
    Uchida, Yoshinori
    Ikeda, Satoshi
    Sekine, Akimasa
    Katano, Takuma
    Tabata, Erina
    Oda, Tsuneyuki
    Okuda, Ryo
    Kitamura, Hideya
    Baba, Tomohisa
    Komatsu, Shigeru
    Ogura, Takashi
    RESPIRATORY INVESTIGATION, 2021, 59 (01) : 99 - 105
  • [30] Efficacy and safety of nintedanib in patients with advanced idiopathic pulmonary fibrosis
    Luca Richeldi
    Martin Kolb
    Stéphane Jouneau
    Wim A. Wuyts
    Birgit Schinzel
    Susanne Stowasser
    Manuel Quaresma
    Ganesh Raghu
    BMC Pulmonary Medicine, 20
12345